Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Submitted by
admin
on January 26, 2025 - 4:13pm
Source:
Motley Fool
News Tags:
Eli Lilly
Verzenio
oncology
cancer
Headline:
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
snippet:
Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments.
Beyond weight loss, the company is quietly building a fast-growing oncology business.
This is an enormous opportunity, and Lilly's clinical pipeline looks well positioned.
Do Not Allow Advertisers to Use My Personal information
